4D Molecular Therapeutics financial statements

Name: Quantus Signal — KR/US technical signal dataset
License: https://www.quantus.kr/signal/terms

4D 멀레큘러 테라퓨틱스NASDAQ:FDMT · Nasdaq · Healthcare

$13.67-1.23%

2026-10-02 close

4D Molecular Therapeutics's published financial data is dated 2026-10-04. 2024 revenue was $0M. 2024 operating profit was −$188M.

Reported results

Quantus Signal · live data · not investment advice · Privacy Policy